Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70
NCT00027131
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
15
Enrollment
OTHER
Sponsor class
Stopped
difficulty with accrual
Conditions
Breast Neoplasms
Interventions
BIOLOGICAL:
Heat Shock Protein 70-peptide complexes (HSP70)
Sponsor
UConn Health